149 related articles for article (PubMed ID: 23154180)
1. Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.
Ekström L; Johansson M; Monostory K; Rundlöf AK; Arnér ES; Björkhem-Bergman L
Biochem Biophys Res Commun; 2013 Jan; 430(1):90-4. PubMed ID: 23154180
[TBL] [Abstract][Full Text] [Related]
2. Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.
Skogastierna C; Johansson M; Parini P; Eriksson M; Eriksson LC; Ekström L; Björkhem-Bergman L
Biochem Biophys Res Commun; 2012 Jan; 417(3):1046-51. PubMed ID: 22222370
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
[TBL] [Abstract][Full Text] [Related]
4. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S
J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073
[TBL] [Abstract][Full Text] [Related]
7. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
[TBL] [Abstract][Full Text] [Related]
8. Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study.
Leszczynska A; Gora M; Plochocka D; Hoser G; Szkopinska A; Koblowska M; Iwanicka-Nowicka R; Kotlinski M; Rawa K; Kiliszek M; Burzynska B
Acta Biochim Pol; 2011; 58(4):635-9. PubMed ID: 22132374
[TBL] [Abstract][Full Text] [Related]
9. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
[TBL] [Abstract][Full Text] [Related]
12. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
13. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
Kalonia H; Kumar P; Kumar A
Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2.
Deakin S; Leviev I; Guernier S; James RW
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2083-9. PubMed ID: 14500290
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.
Prigge JR; Eriksson S; Iverson SV; Meade TA; Capecchi MR; Arnér ES; Schmidt EE
Free Radic Biol Med; 2012 Feb; 52(4):803-10. PubMed ID: 22198266
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
19. Effect of statins on fibroblasts from human nasal polyps and turbinates.
Folli C; Descalzi D; Bertolini S; Riccio AM; Scordamaglia F; Gamalero C; Barbieri M; Passalacqua G; Canonica GW
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):84-9. PubMed ID: 19334372
[TBL] [Abstract][Full Text] [Related]
20. Evidence for intriguingly complex transcription of human thioredoxin reductase 1.
Rundlöf AK; Janard M; Miranda-Vizuete A; Arnér ES
Free Radic Biol Med; 2004 Mar; 36(5):641-56. PubMed ID: 14980707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
